Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
Abstract Intestinal epithelial cell damage caused by SARS-CoV-2 infection was thought to be associated with gastrointestinal symptoms and decreased fecal consistency. The association of the gastrointestinal symptoms with the COVID-19-mediated inflammatory response triggered by the gastrointestinal i...
Enregistré dans:
Auteurs principaux: | Hajar Shokri-Afra, Ahmad Alikhani, Bahman Moradipoodeh, Farshid Noorbakhsh, Hafez Fakheri, Hemen Moradi-Sardareh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e3830e34d4924d4a8b30f4751c3ab77d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fecal calprotectin and microbiota of the gut
par: V. G. Gorokhova, et autres
Publié: (2016) -
Fecal calprotectin in healthy children aged 4–16 years
par: María Roca, et autres
Publié: (2020) -
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
par: Cao Y, et autres
Publié: (2021) -
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
par: Ning Li, et autres
Publié: (2021) -
Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
par: Ning Li, et autres
Publié: (2021)